 Kayla Sprenger
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 12 | 2025 | 213 | 2.000 |
Why?
| | Antibodies, Neutralizing | 5 | 2025 | 286 | 1.860 |
Why?
| | Receptors, Immunologic | 2 | 2025 | 216 | 1.720 |
Why?
| | Ionic Liquids | 4 | 2017 | 6 | 1.710 |
Why?
| | Membrane Glycoproteins | 2 | 2025 | 500 | 1.560 |
Why?
| | AIDS Vaccines | 2 | 2022 | 52 | 1.520 |
Why?
| | Alzheimer Disease | 2 | 2025 | 560 | 1.230 |
Why?
| | Antibody Affinity | 3 | 2025 | 60 | 1.170 |
Why?
| | HIV-1 | 3 | 2022 | 864 | 1.110 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2023 | 83 | 0.970 |
Why?
| | Apolipoprotein E4 | 1 | 2025 | 37 | 0.920 |
Why?
| | Lipoproteins | 1 | 2025 | 168 | 0.880 |
Why?
| | Cellulase | 2 | 2021 | 17 | 0.880 |
Why?
| | Antibodies, Viral | 2 | 2025 | 625 | 0.880 |
Why?
| | Phospholipids | 1 | 2025 | 223 | 0.850 |
Why?
| | Microglia | 1 | 2025 | 251 | 0.800 |
Why?
| | Immunoglobulin Light Chains | 1 | 2023 | 47 | 0.800 |
Why?
| | B-Lymphocytes | 2 | 2025 | 847 | 0.750 |
Why?
| | Lipid Metabolism | 1 | 2025 | 518 | 0.740 |
Why?
| | Cellulose | 1 | 2021 | 39 | 0.730 |
Why?
| | Biocatalysis | 2 | 2017 | 56 | 0.640 |
Why?
| | Viral Vaccines | 1 | 2020 | 98 | 0.620 |
Why?
| | Immunization Schedule | 1 | 2020 | 197 | 0.610 |
Why?
| | HIV Infections | 2 | 2022 | 2836 | 0.550 |
Why?
| | Protein Binding | 6 | 2025 | 2224 | 0.550 |
Why?
| | Silicon Dioxide | 2 | 2017 | 115 | 0.550 |
Why?
| | Lipase | 1 | 2017 | 69 | 0.530 |
Why?
| | Protein Precursors | 1 | 2017 | 134 | 0.530 |
Why?
| | Mixed Function Oxygenases | 1 | 2016 | 40 | 0.500 |
Why?
| | Enzymes | 1 | 2016 | 67 | 0.490 |
Why?
| | Computer Simulation | 2 | 2020 | 978 | 0.490 |
Why?
| | Polysaccharides | 1 | 2016 | 79 | 0.490 |
Why?
| | Thermodynamics | 5 | 2020 | 407 | 0.430 |
Why?
| | Protein Conformation | 3 | 2025 | 934 | 0.430 |
Why?
| | Peptide Fragments | 1 | 2017 | 706 | 0.420 |
Why?
| | Brain | 1 | 2025 | 2668 | 0.410 |
Why?
| | HIV Antibodies | 2 | 2022 | 62 | 0.380 |
Why?
| | Vaccination | 1 | 2020 | 1381 | 0.370 |
Why?
| | Bacterial Proteins | 1 | 2017 | 879 | 0.350 |
Why?
| | Solvents | 2 | 2023 | 109 | 0.330 |
Why?
| | Binding Sites | 2 | 2025 | 1303 | 0.300 |
Why?
| | Germinal Center | 2 | 2025 | 58 | 0.290 |
Why?
| | Imidazoles | 2 | 2017 | 238 | 0.250 |
Why?
| | Models, Immunological | 1 | 2025 | 100 | 0.230 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2025 | 130 | 0.230 |
Why?
| | Enzyme Inhibitors | 2 | 2018 | 840 | 0.220 |
Why?
| | Burkholderiales | 1 | 2024 | 1 | 0.220 |
Why?
| | Polyethylene Terephthalates | 1 | 2024 | 11 | 0.220 |
Why?
| | Adsorption | 2 | 2021 | 149 | 0.220 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2025 | 109 | 0.210 |
Why?
| | Protein Domains | 1 | 2025 | 289 | 0.210 |
Why?
| | Hydrolases | 1 | 2024 | 48 | 0.210 |
Why?
| | Mutation | 3 | 2025 | 3958 | 0.200 |
Why?
| | Models, Chemical | 2 | 2024 | 263 | 0.200 |
Why?
| | Physiological Phenomena | 1 | 2021 | 3 | 0.180 |
Why?
| | Immunoglobulin Variable Region | 1 | 2021 | 80 | 0.180 |
Why?
| | Hydrogen Bonding | 1 | 2021 | 163 | 0.180 |
Why?
| | Spectrum Analysis | 1 | 2021 | 91 | 0.180 |
Why?
| | Humans | 10 | 2025 | 137585 | 0.180 |
Why?
| | Antibodies | 1 | 2023 | 410 | 0.170 |
Why?
| | Enzyme Stability | 2 | 2017 | 70 | 0.170 |
Why?
| | Surface Properties | 1 | 2021 | 413 | 0.170 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2021 | 181 | 0.170 |
Why?
| | Influenza A virus | 1 | 2020 | 107 | 0.160 |
Why?
| | Quartz | 1 | 2019 | 9 | 0.160 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2017 | 560 | 0.160 |
Why?
| | Phosphopeptides | 1 | 2019 | 20 | 0.160 |
Why?
| | Environment | 1 | 2021 | 358 | 0.150 |
Why?
| | Pseudotsuga | 1 | 2018 | 1 | 0.150 |
Why?
| | Cellulases | 1 | 2018 | 1 | 0.150 |
Why?
| | Tannins | 1 | 2018 | 5 | 0.150 |
Why?
| | Titanium | 1 | 2019 | 82 | 0.150 |
Why?
| | Actinobacteria | 1 | 2017 | 13 | 0.140 |
Why?
| | Polyglycolic Acid | 1 | 2017 | 43 | 0.140 |
Why?
| | Protein Unfolding | 1 | 2017 | 31 | 0.140 |
Why?
| | Polystyrenes | 1 | 2017 | 35 | 0.140 |
Why?
| | Animals | 4 | 2025 | 36940 | 0.130 |
Why?
| | Serum Albumin, Bovine | 1 | 2017 | 64 | 0.130 |
Why?
| | Biological Evolution | 1 | 2021 | 474 | 0.130 |
Why?
| | Bacillus subtilis | 1 | 2017 | 66 | 0.130 |
Why?
| | Polyesters | 1 | 2017 | 76 | 0.130 |
Why?
| | Mutagenesis | 1 | 2017 | 179 | 0.130 |
Why?
| | Eukaryota | 1 | 2016 | 57 | 0.120 |
Why?
| | Lactic Acid | 1 | 2017 | 305 | 0.120 |
Why?
| | Archaea | 1 | 2016 | 82 | 0.120 |
Why?
| | Models, Molecular | 1 | 2020 | 1570 | 0.120 |
Why?
| | Antibodies, Monoclonal | 1 | 2021 | 1430 | 0.110 |
Why?
| | Phosphorylation | 1 | 2017 | 1759 | 0.100 |
Why?
| | Peptides | 1 | 2017 | 985 | 0.090 |
Why?
| | Nanoparticles | 1 | 2017 | 481 | 0.090 |
Why?
| | Time Factors | 1 | 2021 | 6828 | 0.080 |
Why?
| | Static Electricity | 2 | 2019 | 118 | 0.070 |
Why?
| | Recycling | 1 | 2024 | 5 | 0.050 |
Why?
| | Drug Stability | 1 | 2021 | 167 | 0.040 |
Why?
| | Drug Approval | 1 | 2021 | 88 | 0.040 |
Why?
| | Protein Stability | 1 | 2021 | 176 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2021 | 208 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 399 | 0.040 |
Why?
| | Kinetics | 1 | 2024 | 1670 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2021 | 237 | 0.040 |
Why?
| | Trichoderma | 1 | 2018 | 8 | 0.040 |
Why?
| | Models, Genetic | 1 | 2021 | 600 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2018 | 114 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2018 | 123 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2018 | 207 | 0.030 |
Why?
| | Electrolytes | 1 | 2017 | 58 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 570 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2017 | 181 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 984 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2025 | 15657 | 0.020 |
Why?
| | United States | 1 | 2021 | 14841 | 0.010 |
Why?
|
|
Sprenger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|